Large-scale testing (Phase 3)Study completedNCT03843541
What this trial is testing
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions
Who this might be right for
Respiratory Tract DiseasesAbnormal Mucus Secretions
Zambon SpA 333